| Product Name | MF | CAS | Details |
|---|
| TRIMETHYLENE SULFONE | C3H6O2S | 5687-92-3 | Details |
| (2S)-9-OXABICYCLO[4.2.1]NON-2-YL PHENYLCARBAMATE | C15H19NO3 | 1217542-29-4 | Details |
| 3-{(E)-[2-(3-TOLUIDINOCARBOTHIOYL)HYDRAZONO]METHYL}PHENYL 3-CHLORO-1-BENZOTHIOPHENE-2-CARBOXYLATE | C24H18ClN3O2S2 | 881457-18-7 | Details |
| Anti-CD11b, (human/mouse), FITC, clone M1/70 Antibody | Details |
| PrEST Antigen CNR1 | Details |
| Amylin/Amylin(Total)Detection Conjugate (11 ml) - COLD PACKS. | Details |
| 6-(4-BROMOPHENYL)-2-METHOXY-4-(4-METHYLPHENYL)NICOTINONITRILE | C20H15BrN2O | 330657-63-1 | Details |
| 2,2-DIMETHYL-1,2-DIHYDRO-ISOQUINOLINIUM, IODIDE | C11H14IN | 53112-34-8 | Details |
| 1-(2-TRIFLUOROMETHYL-BENZOIMIDAZOL-1-YL)-PROPAN-2-ONE | C11H9F3N2O | 321980-88-5 | Details |
| ApoE2 human | 456542-91-9 | Details |
| Butyl methyl ether | C5H12O | 628-28-4 | Details |
| Monoclonal Anti-CD13/Aminopeptidase N antibody produced in mouse | Details |
| Anti-SOX5 | Details |
| CALCIUM BIS(3-((2,4-DIHYDROXY-3,3-DIMETHYLBUTANOYL)AMINO)PROPANOATE) HYDRATE | Details |
| 3dGRO? Organoid Freeze Medium | Details |
| N-Acetyl- |
C7H13NO3S | 1115-47-5 | Details |
| trans,trans-2,4-Hexadien-1-ol | C6H10O | 17102-64-6 | Details |
| Dihexylammonium acetate solution | C14H31NO2 | 366793-17-1 | Details |
| Oxaliplatin Related Compound A | C2H6O6 | 6153-56-6 | Details |
| cis-3-Hexenyl hexanoate | C12H22O2 | 31501-11-8 | Details |
| Manganese(II) cyclohexanebutyrate | C10H18MnO2 | 35542-88-2 | Details |
| Penicillin/Streptomycin/Amphotericin B Solution (100X), Tissue Culture Grade | Details |
| N'-BENZYLIDENE-2-(2-NAPHTHYLOXY)ACETOHYDRAZIDE | C19H16N2O2 | 303065-24-9 | Details |
| SB beta gal Sf9 CTRL | Details |
| (4-(HYDROXY-DI-P-TOLYL-METHYL)-PHENYL)-DI-P-TOLYL-METHANOL | C36H34O2 | 58952-63-9 | Details |
| (1S)-3-(4-METHOXYBENZOYL)-1,2,2-TRIMETHYLCYCLOPENTANECARBOXYLIC ACID | C17H22O4 | 1217494-98-8 | Details |
| Details |
| 4-(Difluoromethoxy)benzoic acid | C8H6F2O3 | 4837-20-1 | Details |
| 3-IODOBENZANTHRONE | C17H9IO | 36189-45-4 | Details |
| Anti-ZNF461 antibody produced in rabbit | Details |
| Monoclonal Anti-CAPZB, (C-terminal) antibody produced in mouse | Details |
| 2-((1-ME-1H-BENZIMIDAZOL-2-YL)THIO)-N'-(1-(3-NITRO-PH)ETHYLIDENE)ACETOHYDRAZIDE | C18H17N5O3S | 307346-77-6 | Details |
| Neu5Acα3Galβ-C3-PAA-biot | Details |
| Molymod? bonding links | Details |
| PluriSTEM? Human ES/iPS Cell Medium | Details |
| 3D-PHAD | C82H158N3O20P | 1699735-79-9 | Details |
| Diacylglycerol Kinase Inhibitor I | C27H26FN3OS | 93076-89-2 | Details |
| PF-6808472 | C25H27FN8O3S | 2088112-70-1 | Details |
| Anti-Integrin α5 Antibody, CT, Intracellular | Details |
| N-(4-CHLOROBENZYL)-5-METHYL-3-ISOXAZOLAMINE | 287918-27-8 | Details |
| 3-FLUOROBENZALDEHYDE N-CYCLOHEXYLTHIOSEMICARBAZONE | C14H18FN3S | 880022-38-8 | Details |
| BCMA Blocking Peptide for PRS2397 | Details |
| 4-(2-(HYDROXY(PHENYL)ACETYL)CARBOHYDRAZONOYL)PHENYL 3,4-DIMETHOXYBENZOATE | C24H22N2O6 | 764692-58-2 | Details |
| 5-INDANESULFONAMIDE | C9H11NO2S | 35203-93-1 | Details |
| Methyl (4R,5S)-2,2,5-trimethyl-1,3-dioxolane-4-carboxylate | C8H14O4 | 78086-72-3 | Details |
| RCL S235385 | 51099-19-5 | Details |
| Anti-HMGB1 Antibody, clone HMG1-5H6 | Details |
| 1,2,4-Benzenetricarboxylic 1,2-anhydride | C9H4O5 | 552-30-7 | Details |
| 1-ETHYL-2-(2-(2-HYDROXY-PHENYL)-VINYL)-PYRIDINIUM, IODIDE | C15H16INO | 36372-40-4 | Details |
| Anti-AGO1 antibody produced in rabbit | Details |
| N'-(4-BUTOXYBENZYLIDENE)-3-(4-((4-ME-BENZYL)OXY)PH)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C29H30N4O3 | 634897-03-3 | Details |
| 4-Nitrophthalic anhydride | C8H3NO5 | 5466-84-2 | Details |
| (11beta)-9-fluoro-11,17-dihydroxypregn-4-ene-3,20-dione | C21H29FO4 | 337-03-1 | Details |
| (+/-)-JQ1 | C23H25ClN4O2S | 1268524-69-1 | Details |
| Anti-CNGA2 antibody produced in rabbit | Details |
| Ace cylindrical reaction flask | Details |
| Anti-CIC | Details |
| PrEST Antigen HTR1A | Details |
| Dexamethasone Ethyl Ester | C23H31FO5 | 2991360-83-7 | Details |
| 4-[4-(DIMETHYLAMINO)PHENYL]-2,7,7-TRIMETHYL-5-OXO-N-[3-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBOXAMIDE | C28H30F3N3O2 | 421567-31-9 | Details |
| ethyl 6-oxo-4-phenyl-3-piperidinecarboxylate | C14H17NO3 | 408520-00-3 | Details |
| 2-MEO-4-(2-((4-METHYLPHENOXY)ACETYL)CARBOHYDRAZONOYL)PHENYL 2,4-DICHLOROBENZOATE | C24H20Cl2N2O5 | 328571-37-5 | Details |
| 4-(2-(2-(4-(BENZYLOXY)PHENOXY)PROPANOYL)CARBOHYDRAZONOYL)PHENYL 3-PHENYLACRYLATE | C32H28N2O5 | 880022-20-8 | Details |
| ChromegaChiral Chiral CCO, 3 Micron HPLC Column | Details |
| [ |
C48H73N13O12 | 202120-08-9 | Details |
| Anti-IKZF3 antibody produced in mouse | Details |
| N-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-2-{[3-CYANO-6-(2-THIENYL)-4-(TRIFLUOROMETHYL)-2-PYRIDINYL]SULFANYL}ACETAMIDE | C21H10F9N3OS2 | 330643-81-7 | Details |
| Anti-TRIM25 antibody produced in rabbit | Details |
| Anti-ADCY3 antibody produced in rabbit | Details |
| N-(3-CHLORO-2-METHYLPHENYL)-2-(2,3,4,6-TETRACHLOROPHENOXY)ACETAMIDE | C15H10Cl5NO2 | 853311-20-3 | Details |
| Ethyl 5-(4-(methylthio)phenyl)isoxazole-3-carboxylate | C13H13NO3S | 925006-98-0 | Details |
| 1-Bromododecane-1-13C | C12H25Br | 88170-33-6 | Details |
| 1-(4-Ethylphenyl)ethanamine | C10H15N | 147116-33-4 | Details |
| N-(2,2,2-TRICHLORO-1-((2-TOLUIDINOCARBOTHIOYL)AMINO)ETHYL)PROPANAMIDE | C13H16Cl3N3OS | 324068-58-8 | Details |
| 3-[(3,5-Difluorophenoxy)methyl]piperidine | C12H15F2NO | 1063734-82-6 | Details |
| N-(2-PHENYLPROPYLIDENEAMINO)-PHTHALIMIDE | C17H14N2O2 | 116594-85-5 | Details |
| 3-(2-CHLORO-PHENYL)-N-(TETRAHYDRO-FURAN-2-YLMETHYL)-ACRYLAMIDE | 324071-02-5 | Details |
| N-(4-((2-(3-HYDROXYBENZYLIDENE)HYDRAZINO)CARBONYL)PHENYL)BENZENESULFONAMIDE | C20H17N3O4S | 29645-77-0 | Details |
| FLEXIBLE, DIA 22 MM, LG 589MM, 316L | Details |
| Mobius? System TFF80-Installation and Operational Qualification execution protocol in English and travel | Details |
| 2-((5-((1-NAPHTHYLMETHYL)THIO)-1,3,4-THIADIAZOL-2-YL)THIO)ACETAMIDE | C15H13N3OS3 | 613228-22-1 | Details |
| MLK4, Active | Details |
| N-Nitroso-N-ethylurea | C3H7N3O2 | 759-73-9 | Details |
| Isopropylamine | C3H9N | 75-31-0 | Details |
| Anti-TNFSF13 (APRIL) Antibody, clone A3D8 | Details |
| ETHYL (2-[[(4-NITROANILINO)CARBOTHIOYL]AMINO]-1,3-THIAZOL-4-YL)ACETATE | C14H14N4O4S2 | 957757-03-8 | Details |
| 2-CHLORO-N-(2,2,2-TRICHLORO-1-(3-(4-FLUORO-PHENYL)-THIOUREIDO)-ETHYL)-BENZAMIDE | 351005-75-9 | Details |
| 3-(2-fluorophenyl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole hydrobromide | Details |
| SPARE UV LAMP | Details |
| N-(1-(3-(2-BR-PHENYL)-THIOUREIDO)-2,2,2-TRICHLORO-ETHYL)-2,4-DICHLORO-BENZAMIDE | 303754-20-3 | Details |
| 1,3-DIPHENYL-1,2,3-PROPANETRIONE 2-OXIME | C15H11NO3 | 51210-89-0 | Details |
| Glucoraphenin potassium salt | C12H22KNO10S3 | 108844-81-1 | Details |
| Anti-TOE1 antibody produced in rabbit | Details |
| Anti-OSM antibody produced in mouse | Details |
| 2-(4-CL-PH)-2-OXOETHYL 6-ME-2-(4-(4-PROPYLCYCLOHEXYL)PH)-4-QUINOLINECARBOXYLATE | C34H34ClNO3 | 355826-19-6 | Details |
| 2-{[5-(4-BROMOPHENYL)-4-PHENYL-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N'-[(E)-(3-HYDROXYPHENYL)METHYLIDENE]ACETOHYDRAZIDE | C23H18BrN5O2S | 314772-96-8 | Details |
| (5Z)-5-{[3-(4-BUTOXY-2-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE}-3-(TETRAHYDRO-2-FURANYLMETHYL)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE | C29H31N3O3S2 | 955866-05-4 | Details |
| 3-(3-CHLORO-4-METHYLANILINO)-1-(4-CHLOROPHENYL)-1-PROPANONE | C16H15Cl2NO | 477334-01-3 | Details |
| Isoeugenol, predominantly trans | C10H12O2 | 5932-68-3 | Details |
| ()-trans-(1S,2S)-U-50488 hydrochloride hydrate | C19H27Cl3N2O | 114528-79-9 | Details |
| Product Total： Product Page： | ||||
| 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 | ||||